Primary pulmonary coccidioidomycosis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Primary pulmonary coccidioidomycosis
Synonyms	Valley fever, San Joaquin Valley fever, Desert rheumatism
Pronounce	N/A
Specialty	N/A
Symptoms	Fever, cough, chest pain, fatigue, shortness of breath
Complications	Chronic pulmonary coccidioidomycosis, disseminated coccidioidomycosis
Onset	1 to 3 weeks after exposure
Duration	Weeks to months
Types	N/A
Causes	Coccidioides immitis or Coccidioides posadasii
Risks	Immunocompromised, pregnancy, diabetes mellitus, African American or Filipino descent
Diagnosis	Serology, culture, PCR
Differential diagnosis	Tuberculosis, pneumonia, lung cancer
Prevention	Avoiding exposure in endemic areas
Treatment	Antifungal medications such as fluconazole or itraconazole
Medication	N/A
Prognosis	Generally good with treatment, but can be severe in immunocompromised individuals
Frequency	Endemic in the Southwestern United States, parts of Mexico, and Central America
Deaths	N/A

Primary Pulmonary Coccidioidomycosis is a type of lung disease caused by the fungus Coccidioides. This disease is also known as Valley Fever, named after the San Joaquin Valley in California, where the fungus is endemic.

Etiology

Primary Pulmonary Coccidioidomycosis is caused by the inhalation of Coccidioides spores, which are found in the soil and dust of certain arid regions, particularly the southwestern United States, northern Mexico, and parts of Central America and South America. The two species of Coccidioides that cause the disease are Coccidioides immitis and Coccidioides posadasii.

Symptoms

The symptoms of Primary Pulmonary Coccidioidomycosis can range from mild to severe, and may include fever, cough, chest pain, fatigue, rash, and weight loss. In some cases, the disease can progress to disseminated coccidioidomycosis, which can affect other parts of the body and cause more serious symptoms.

Diagnosis

Diagnosis of Primary Pulmonary Coccidioidomycosis is typically made through laboratory testing, including serology and culture of respiratory specimens. Imaging studies, such as chest X-ray or CT scan, may also be used to identify abnormalities in the lungs.

Treatment

Treatment for Primary Pulmonary Coccidioidomycosis typically involves antifungal medication, such as fluconazole or itraconazole. In severe cases, hospitalization and more aggressive treatment may be required.

Prevention

Prevention strategies for Primary Pulmonary Coccidioidomycosis include avoiding activities that stir up dust in endemic areas, using respiratory protection when such activities cannot be avoided, and educating individuals about the disease and its symptoms.

This article is a stub related to fungus. You can help WikiMD by expanding it!